Literature DB >> 14562639

Obstetric and gynecologic complications in women with Marfan syndrome.

Jessica Rahman1, Farooq Z Rahman, Waheeda Rahman, Suleiman A al-Suleiman, Mohammad Sayedur Rahman.   

Abstract

OBJECTIVE: To analyze the maternal and fetal outcomes of pregnancy and gynecologic problems in women with Marfan syndrome. STUDY
DESIGN: The outcomes of 14 pregnancies in 4 women with Marfan syndrome were prospectively observed between January 1988 and December 2000. The cardiovascular and obstetric complications were analyzed. During pregnancy all the patients were carefully monitored with serial echocardiography and close attention to symptoms.
RESULTS: Of the 14 pregnancies, 5 (35.7%) ended in abortion, and 3 of them occurred in the early second trimester due to cervical incompetence. Premature onset of labor occurred in 2 pregnancies at 31 and 34 weeks. Postpartum hemorrhage complicated 3 deliveries, and inversion of the uterus occurred in 1 patient. Significant cardiovascular complications occurred in 2 patients, who required surgical correction of the aortic aneurysm and replacement of the aortic valve. In one patient the operation was performed within hours of vaginal delivery, and the other patient underwent surgery 8 weeks postpartum. No maternal death occurred in the study. One infant in the series was diagnosed as having Marfan syndrome. A premature infant delivered at 31 weeks died on the second day of life.
CONCLUSION: Women with Marfan syndrome are at high risk of aortic dissection in pregnancy even in the absence of preconceptional aortic root dilatation. Obstetric complications in patients with this condition have been underreported in the past. Women with aortic root dilatation of < 40 mm usually tolerate pregnancy well, with good maternal and fetal outcomes. Women with Marfan syndrome should be counseled regarding the risk of pregnancy to both mother and fetus. Patients who have cardiac decompensation or aortic dilatation > 40 mm are advised to avoid pregnancy.

Entities:  

Mesh:

Year:  2003        PMID: 14562639

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  7 in total

1.  Epidural anesthesia for cesarean section in a patient with Marfan syndrome and dural ectasia -A case report-.

Authors:  Gahyun Kim; Justin Sangwook Ko; Duck Hwan Choi
Journal:  Korean J Anesthesiol       Date:  2011-03-30

Review 2.  Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity.

Authors:  E A Anum; L D Hill; A Pandya; J F Strauss
Journal:  Placenta       Date:  2009-01-18       Impact factor: 3.481

3.  Health disparities in risk for cervical insufficiency.

Authors:  Emmanuel A Anum; Haywood L Brown; Jerome F Strauss
Journal:  Hum Reprod       Date:  2010-07-19       Impact factor: 6.918

4.  Sex, pregnancy and aortic disease in Marfan syndrome.

Authors:  Marjolijn Renard; Laura Muiño-Mosquera; Elise C Manalo; Sara Tufa; Eric J Carlson; Douglas R Keene; Julie De Backer; Lynn Y Sakai
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

5.  Epidural Anesthesia for Cesarean Section in a Pregnant Woman with Marfan Syndrome and Dural Ectasia.

Authors:  Franco Pepe; Mariagrazia Stracquadanio; Francesco De Luca; Agata Privitera; Elisabetta Sanalitro; Puccio Scarpinati
Journal:  Case Rep Obstet Gynecol       Date:  2017-05-22

6.  Management of worsening aortic dilation and insufficiency in a 20-week pregnant woman: a case report.

Authors:  Amy Shah; Johanna Schwarzenberger; Dorina Gui; Richard Hong; Angela Chen
Journal:  Case Rep Obstet Gynecol       Date:  2011-07-10

7.  Aortic Complications Associated With Pregnancy in Marfan Syndrome: The NHLBI National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC).

Authors:  Mary J Roman; Norma L Pugh; Tabitha P Hendershot; Richard B Devereux; Hal Dietz; Kathryn Holmes; Kim A Eagle; Scott A LeMaire; Dianna M Milewicz; Shaine A Morris; Reed E Pyeritz; William J Ravekes; Ralph V Shohet; Michael Silberbach
Journal:  J Am Heart Assoc       Date:  2016-08-11       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.